Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Phoenix-Micron, Inc. launches the next generation of its MICRON in vivo ophthalmic imaging platform for small animal research


News provided by

Phoenix-Micron, Inc.

Apr 21, 2023, 06:00 ET

Share this article

Share toX

Share this article

Share toX


The all-new MICRON® 5 platform delivers advanced performance, repeatability, and imaging workflow efficiency.

BEND, Ore., April 21, 2023 /PRNewswire-PRWeb/ -- Phoenix-Micron, Inc. today announced the launch of the all-new Phoenix MICRON® 5 imaging system, the latest breakthrough in small animal ophthalmic imaging technology. With over 450 published studies utilizing MICRON imaging systems, the MICRON platform has provided researchers with precision tools for imaging and data capture for over 14 years. The patented MICRON 5 is the next generation of the Company's industry-leading platform to power eye and eye-brain research. Orders are being accepted for MICRON 5 systems now, and first deliveries are expected this summer.

Designed to enhance efficiency and repeatability, the MICRON 5 platform boasts a range of core, patent-pending features, including interchangeable imaging sensors and software-controlled camera operation, expanded excitation and barrier filter capabilities, and new depth of field adjustments. These new capabilities provide endless opportunities for researchers to fine-tune their in vivo imaging and capture more precise data more easily.

Designed to enhance efficiency and repeatability, the MICRON 5 platform boasts a range of core, patent-pending features, including interchangeable imaging sensors and software-controlled camera operation, expanded excitation and barrier filter capabilities, and new depth of field adjustments.

Post this

Understanding the importance of protecting the investment MICRON customers make in capital equipment, the MICRON 5 camera is compatible with the imaging modalities from the prior MICRON IV generation. This allows for a smooth upgrade to the newest technology platform with the lowest total-cost-of-ownership.

"We are thrilled to introduce the all-new Phoenix MICRON 5 platform to the research community," said Scott Carr, CEO Of Phoenix-Micron, Inc. "Our team has spent the last several years developing the software and hardware that powers the MICRON 5 platform to bring researchers the latest imaging and data capture capabilities. We are in awe of the discoveries in science and medicine that our research customers develop, and we are committed to continuing our tradition of innovation in order to meet our customers' needs with the MICRON 5."

The MICRON 5 introduces powerful capabilities to enhance the quality of imaging and data capture in experiments with small animals:

  • Interchangeable camera sensors offer the option to fine-tune fidelity, quantum efficiency, and spatial precision to more precisely image specific cellular and molecular features
  • Focus, illumination, and filter selection are now under software control, speeding the imaging workflow and increasing the metadata that the MICRON 5 camera can capture about each image, enhancing analysis and experiment repeatability
  • Excitation and barrier filters have been completely redesigned to radically improve usability, automatically detect installed filters, and make it easier to use a wide range of wavelengths to tailor illumination and sampled light to your requirements
  • A new adjustable aperture has been added to offer control over depth of field, enabling better imaging of dimensional structures including tumors, cysts, and properties of the vitreous. In addition, this improves the ability to image highly reflective retina, such as those present in albino rodents.
  • The MICRON 5 camera is fully compatible with the new MICRON LT2 lens technology, shortening the time required to quickly change imaging modalities with precision alignment
  • The MICRON 5 camera is fully compatible with the newly released MICRON Software Suite, which delivers advanced image and data management capabilities to help efficiently power your research and data analysis

For more information on the Phoenix MICRON 5, please click here.

About Phoenix-Micron, Inc.: Phoenix-Micron, Inc.is a global leader in in vivo ophthalmic imaging of laboratory animals. MICRON systems are optimized for eye and eye-brain research. The patented MICRON platform delivers seven essential imaging modalities in a compact footprint, backed by world-class service, that's ideal for the exacting data capture and physical space requirements of small animal research labs. Each piece of the MICRON system is designed to ease the researcher's workflow and capture and manage the high-resolution ophthalmic images and associated data that helps bring ophthalmic research to life. Since its initial launch in 2007, MICRON camera systems have been installed in hundreds of ophthalmic and neurologic research labs in more than 25 countries. Found in 11 of the world's top 12 research institutes, MICRON systems have been used by authors of more than 450 published studies. For more information about Phoenix-Micron, Inc. and the Phoenix MICRON® in-vivo imaging system, contact Jen King, [email protected].

Media Contact

Jen King, Phoenix-Micron, Inc., 1 408-234-3687, [email protected]

SOURCE Phoenix-Micron, Inc.

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.